FDA clears Beckman Coulter Life Sciences AQUIOS STEM System for stem cell analysis

Sage Ther­a­peu­tics an­nounced plans for a “pipeline pri­or­i­ti­za­tion and a work­force re­or­ga­ni­za­tion” on Mon­day morn­ing af­ter the FDA re­ject­ed its ex­per­i­men­tal pill for ma­jor de­pres­sive

The re­ports of Ab­b­Vie’s demise have been great­ly ex­ag­ger­at­ed. Gone are the wor­ries of Hu­mi­ra com­pe­ti­tion and its mon­u­men­tal patent cliff. The “ Sign up